This handout is for atrial flutter (typical and atypical). Your care team identified this based on: palpitations or fluttering sensation.
Other reasons your team may use this plan: dyspnea, fatigue, decreased exercise tolerance; syncope or pre-syncope; flutter on 12-lead ecg or telemetry.
Take these medications exactly as prescribed. Do not stop or change a dose without talking to your provider.
| Medication | Starting dose | How | When | What it does |
|---|---|---|---|---|
| metoprolol_tartrate | 5 mg IV q5min × 3 then PO 25–50 mg BID | IV/PO | IV q5min × 3 → PO BID | AVN slowing; HR target 80–110 — ACC/AHA 2024 (PMID 38033089) |
| apixaban | 5 mg BID (2.5 mg if 2 of: ≥80 yr, ≤60 kg, Cr ≥1.5) | PO | BID | ARISTOTLE (Granger NEJM 2011 PMID 21870978) — same indication as AF; ACC/AHA 2024 Class I |
Plan: Atrial flutter — phenotype-stepwise master ladder (typical CTI / atypical / unstable / post-cardiac-surgery / stable RVR) — ACC/AHA 2024 (Joglar PMID 38033089); ESC 2024 (PMID 39210723); Calkins HRS/EHRA/ECAS 2007 (PMID 28506916)
Contact your care team if any of the following happen:
Call 911 or go to the nearest emergency room right away if you have:
EP referral for CTI ablation; cardiology q3–6 mo; chronic AC review; lifestyle (alcohol, weight, OSA)
Guideline: 2024 ACC/AHA/ACCP/HRS AF + AFL Joint Guideline (Joglar Circulation 2024 PMID 38033089); ESC 2024 AF (Van Gelder EHJ 2024 PMID 39210723); HRS/EHRA/ECAS 2017 catheter ablation expert consensus (Calkins PMID 28506916)